[go: up one dir, main page]

NO20063943L - Kombinasjon av voriconazol og en antifungal CYP2C19 inhibitor - Google Patents

Kombinasjon av voriconazol og en antifungal CYP2C19 inhibitor

Info

Publication number
NO20063943L
NO20063943L NO20063943A NO20063943A NO20063943L NO 20063943 L NO20063943 L NO 20063943L NO 20063943 A NO20063943 A NO 20063943A NO 20063943 A NO20063943 A NO 20063943A NO 20063943 L NO20063943 L NO 20063943L
Authority
NO
Norway
Prior art keywords
voriconazole
combination
cyp2c19 inhibitor
antifungal cyp2c19
antifungal
Prior art date
Application number
NO20063943A
Other languages
English (en)
Inventor
Michael John Humphrey
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20063943L publication Critical patent/NO20063943L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Oppfinnelsen tilveiebringer en terapeutisk kombinasjon som innbefatter voriconazol og en antifungal CYP2C19 inhibitor i spesifikke mengder og vektforhold. Farmasøytiske sammensetninger, enhetsdoseringsformer og kit som innbefatter voriconazol og en antifungal CYP2C19 inhibitor og deres anvendelse ved behandling av fungale infeksjoner er også tilveiebrakt.
NO20063943A 2004-02-04 2006-09-04 Kombinasjon av voriconazol og en antifungal CYP2C19 inhibitor NO20063943L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0402491.5A GB0402491D0 (en) 2004-02-04 2004-02-04 Medicaments
US54566304P 2004-02-17 2004-02-17
PCT/IB2005/000098 WO2005084671A2 (en) 2004-02-04 2005-01-13 Combination of voriconazole and an antifungal cyp2c19 inhibitor

Publications (1)

Publication Number Publication Date
NO20063943L true NO20063943L (no) 2006-11-02

Family

ID=34889126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063943A NO20063943L (no) 2004-02-04 2006-09-04 Kombinasjon av voriconazol og en antifungal CYP2C19 inhibitor

Country Status (22)

Country Link
US (1) US20050182074A1 (no)
EP (1) EP1713477B1 (no)
JP (1) JP2007520542A (no)
KR (1) KR100817367B1 (no)
CN (1) CN1913887A (no)
AR (1) AR047701A1 (no)
AT (1) ATE409477T1 (no)
AU (1) AU2005219017B2 (no)
BR (1) BRPI0507399A (no)
CA (1) CA2488300C (no)
DE (1) DE602005010049D1 (no)
DK (1) DK1713477T3 (no)
ES (1) ES2313284T3 (no)
GB (1) GB0402491D0 (no)
IL (1) IL176771A0 (no)
NO (1) NO20063943L (no)
PT (1) PT1713477E (no)
RU (1) RU2345769C2 (no)
SI (1) SI1713477T1 (no)
TW (1) TW200536846A (no)
WO (1) WO2005084671A2 (no)
ZA (1) ZA200605749B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007012967A2 (en) * 2005-07-27 2007-02-01 Pfizer Limited Combination of voriconazole and fluconazole
WO2009053993A2 (en) * 2007-10-22 2009-04-30 Lee Pharma Limited Process for preparation of novel salt of voriconazole oxalate form-c
RU2566262C2 (ru) * 2011-06-15 2015-10-20 Синтон Бв Стабилизированная композиция вориконазола
US9029342B2 (en) 2012-09-17 2015-05-12 Board Of Regents Of The University Of Texas System Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof
WO2018144841A1 (en) * 2017-02-03 2018-08-09 Board Of Regents, The University Of Texas System Topical voriconazole for the treatment of pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0069442B1 (en) * 1981-06-06 1985-02-20 Pfizer Limited Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
US5278175A (en) * 1990-02-02 1994-01-11 Pfizer Inc. Triazole antifungal agents
GB9518953D0 (en) * 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO1999009997A1 (en) * 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System Edta and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
US6602496B2 (en) * 2001-07-05 2003-08-05 Closure Medical Corporation Adhesive treatment for tinea corporis
US20050043251A1 (en) * 2003-08-20 2005-02-24 Fairfield Clinical Trials, Llc Method of treatment of otitis externa

Also Published As

Publication number Publication date
CA2488300A1 (en) 2005-08-04
PT1713477E (pt) 2008-11-26
KR100817367B1 (ko) 2008-03-27
US20050182074A1 (en) 2005-08-18
JP2007520542A (ja) 2007-07-26
WO2005084671A3 (en) 2006-06-22
TW200536846A (en) 2005-11-16
SI1713477T1 (sl) 2009-02-28
DE602005010049D1 (de) 2008-11-13
KR20060120239A (ko) 2006-11-24
EP1713477B1 (en) 2008-10-01
RU2006128291A (ru) 2008-03-10
EP1713477A2 (en) 2006-10-25
ATE409477T1 (de) 2008-10-15
CN1913887A (zh) 2007-02-14
BRPI0507399A (pt) 2007-07-10
AR047701A1 (es) 2006-02-08
IL176771A0 (en) 2006-10-31
RU2345769C2 (ru) 2009-02-10
AU2005219017B2 (en) 2008-07-24
WO2005084671A2 (en) 2005-09-15
AU2005219017A1 (en) 2005-09-15
GB0402491D0 (en) 2004-03-10
ES2313284T3 (es) 2009-03-01
DK1713477T3 (da) 2008-11-24
ZA200605749B (en) 2008-08-27
CA2488300C (en) 2008-09-30

Similar Documents

Publication Publication Date Title
NO20080785L (no) Behandling av kreft
NO20066050L (no) Substituerte indazoler, sammensetninger inneholdende disse samt fremstilling og anvendelse derav
CL2007003520A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
BRPI0616630B8 (pt) compostos de pirazol substituídos
CL2008002130A1 (es) Compuestos derivados de 2-amino-cromen-4-ona; composicion farmaceutica que lo comprende; y uso en el tratamiento de una enfermedad que es aliviada por la inhibicion de la proteina quinasa dependiente de adn (adn-pk), tal como cancer.
CL2007002640A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
NO20081788L (no) Cyklopropylaminer som modulatorer av histamin-H3-reseptoren
CL2007002642A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
ECSP067076A (es) Derivados de pirimidina urea como inhibidores de la quinasa
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
NO20082376L (no) Farmasoytiske sammensetninger
NO20082088L (no) Azetidiner som MEK-inhibitorer for behandling av proliferative sykdommer
ES2422556T3 (es) Tratamiento de hepatitis vírica
NO20082191L (no) Forbindelser
DK1928840T3 (da) 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer
NO20084593L (no) Okulaere allergibehandlinger
NO341679B1 (no) Substituerte pyridylamidforbindelser, fremstilling av slike og farmasøytiske sammensetninger inneholdende slike, samt anvendelse som modulatorer av histamin H3-reseptoren
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2007016338A3 (en) Use of chk2 kinase inhibitors for cancer treatment
CR8495A (es) Tratamiento de osteoporosis relacionado con terapia con inhibidor de aromatasa
NO20081292L (no) Pentasykliske kinaseinhibitorer
NO20063943L (no) Kombinasjon av voriconazol og en antifungal CYP2C19 inhibitor
CL2007003251A1 (es) Compuestos derivados de 1h-pirazoles sustituidos, inhibidores de reacciones catalizadas por una quinasa; su procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; uso de los compuestos principales, utiles en el tratamiento del cancer.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application